tissue and organs. 19 CDKN1A plays a key role in the control of cellcycle arrest. [20] [21] [22] Of note, very recently, CDKN1A has been shown to be a miR-4295-targeting gene in anaplastic thyroid carcinoma. 23 However, the role of miR-4295 in PC cell growth has not been reported.
We have studied the tumour biology of PC for years. 24 , 25 Here,
we studied the effects of GRh2 on the growth of PC cells. Using PC3
and DU145 PC cell lines, we found that GRh2 dose-dependently inhibited PC cell proliferation, but did not alter cell apoptosis, seemingly through downregulation of miR-4295, which inhibits protein translation of CDKN1A.
| MATERIALS AND METHODS

| Human PC cell lines and GRh2
PC3 and DU145 were human prostatic cancer cell lines purchased from American Type Culture Collection (ATCC). PC3 and DU145 cells were maintained in RPMI 1640 medium (Thermo Scientific, Rockford, IL, USA) supplied with 5% foetal bovine serum (Thermo Scientific).
GRh2 was purchased from Weikeqi Bioscience, Chengdu, China and was exposed to the cultured PC cells at a dose of 0.01, 0.1 and 1 mg/ mL. Control non-GRh2 solution was shown as 0 mg/mL GRh2.
| Cell transfection, bioinformatics, and dual luciferase-reporter assay
PC3 and DU145 cells were transfected with plasmids carrying miR- miRNAs for CDKN1A in mice and humans were predicted using online tools from TargetScan, based on a context++ score system, as has been described. 26 The dual-luciferase 3′-UTR reporter plasmids include a p3′-UTR-CDKN1A that contains the wild-type CDKN1A 3′-UTR-binding site in luciferase reporter plasmid and a p3′-UTR-CDKN1A-mut that contains the mutant CDKN1A 3′-UTR. Either 3′-UTR plasmid was co-transfected into PC3 cells with a plasmid carrying either miR-4295 or as-miR-4295. The luciferase activity was assessed 48 hours after transfection.
| MTT assay
Cell viability was assessed in cultured cells using an MTT Kit (Roche, Indianapolis, IN, USA), in which the quantification was done at 540 nm absorbance value (OD) from 5 repeats.
| Quantitative PCR (RT-qPCR)
A miRNeasy mini kit (Qiagen, Burlingame, CA, USA) was used to isolate total RNA including miRNAs from cultured cells. Synthesis of cDNA and RT-qPCR were performed using QuantiTect Reverse Transcription Kit and QuantiTect SYBR Green PCR Kit, respectively (Qiagen).
Specific primers were all purchased from Qiagen. Data were assessed using 2 −△△Ct method. Values of genes were obtained after sequential normalization against housekeeping control gene β-actin and then the experimental control condition.
| Western blotting
Proteins were isolated from cultured cells with RIPA lysis buffer (Bio-Rad, Shanghai, China). Protein concentration was assessed with a BCA protein assay kit (Bio-Rad). Cell lysates were mixed with 4× SDS loading buffer at 3:1 (Bio-Rad) and separated on SDSpolyacrylamide gels after heating at 95°C. Transferred PVDF membrane was first probed with a primary antibody, and then with a horseradish peroxidase-conjugated second antibody, after which photographing was done using enhanced chemiluminescent system. Primary antibodies were rabbit anti-CDKN1A and rabbit anti-β-actin (Cell Signaling, Carpinteria, CA, USA). Secondary antibody is HRP-conjugated anti-rabbit (Dako, Carpinteria, CA, USA). Protein levels were assessed using NIH ImageJ software (Bethesda, MA, USA).
| BrdU and TUNEL staining
BrdU ( 
| Statistical analysis
The statistical studies were done with GraphPad prism software (GraphPad Software, Inc., La Jolla, CA, USA), in which a one-way ANOVA with a Bonferroni correction was applied for comparison among several groups. Mean ± SD was used to represent values, and the differences were considered significant if P < .05.
| RESULTS
| GRh2 dose-dependently suppresses PC cell proliferation
Here, we aimed to examine the effects of GRh2 on PC cell growth.
In 2 commonly used PC cell lines PC3 and DU145, we found that 
| GRh2 inhibits PC cell proliferation through upregulation of CDKN1A
In order to understand the underlying mechanisms, we exam- 
| MiR-4295 targets 3′-UTR of CDKN1A mRNA to suppress its protein translation
We used bioinformatics tools to screen miRNAs that bind to 3′-UTR of CDKN1A and found miR-4295 as the one candidate that was specifically and dose-dependently downregulated by GRh2 ( Figure 3A) . Indeed, miR- plasmid from either wt CDKN1A 3′-UTR or mut CDKN1A 3′-UTR, and then luciferase activity was analysed in a dual luciferase reporter assay.
We found that miR-4295 depletion increased luciferase activity of wt CDKN1A 3′-UTR, while re-expression of miR-4295 reduced luciferase activity of wt CDKN1A 3′-UTR but not those of mut CDKN1A 3′-UTR ( Figure 3D ). These results suggest that miR-4295 specifically binds to the 3′-UTR of CDKN1A mRNA to suppress its protein translation in PC cells. Then, the intact 3′-UTR of wild-type CDKN1A mRNA (wt CDKN1A 3′-UTR) and the 3′-UTR of CDKN1A mRNA with a mutant at miR-4295-binding site (mut CDKN1A 3′-UTR) were respectively cloned into luciferase reporter plasmids. PC3 cells were then co-transfected with 2 certain plasmids, and luciferase activity was assessed a dual luciferase reporter assay. *P < .05. NS: non-significant. N = 5 growth ( Figure 5A,B) . Moreover, the abolishment of the GRh2 effects on cell growth appeared to result from the abolishment of the GRh2 effects on cell proliferation, shown by quantification ( Figure 5C ), and by representative images ( Figure 5D ). Together, these data suggest that GRh2 inhibits PC cell growth through suppression of miRNA-4295 that activates CDKN1A ( Figure 6 ).
| DISCUSSION
GRh2 is the major bioactive component in ginseng, and its antitumour activity had been reported in quite a few of previous studies.
For example, Yang et al 27 showed that GRh2 enhanced colorectal cancer cell death, seemingly through regulation of the phosphorylation of ERK1/2 and histone H3. In several other studies, GRh2 was shown to suppress cancer cell proliferation in human breast carcinoma cells, 7, 28 human ovarian cancer cells, 29 through a variety of targets related to cell-cycle control, for example, p15, p21, p27, Cdk2, cyclin E-dependent kinase. Interestingly, GRh2 was also shown to dose-dependently reduce Lgr5-positive squamous cancer stem-like cells. 6 Moreover, GRh2 was shown to alter miRNAs to regulate the non-small-cell lung cancer cell proliferation. 30 However, tumour growth in these cancers that had been treated with GRh2 was not the first reason that contributes to the tumour malignancy, since these cancers were quite invasive which renders their invasion and The fact that GRh2 dose-dependently decreased CDKN1A pro- an inhibitory effect of GRh2 on PC growth, seemingly through regulation of both cell-cycle regulators and MMPs. 9 However, the exact underlying molecular mechanisms were not determined in this study. 9 In another study on anaplastic thyroid carcinoma, control of CDKN1A
by miR-4295 has been reported. 23 However, to the best of our knowledge, our study is the first one to show a role of miR-4295/CDKN1A
in PC cell growth which could be regulated by application of GRh2.
Taking into account of the importance of control of PC growth, our study should provide an important basis for further investigation of the possible application of GRh2 in PC therapy.
